Sancilio and Company Announces New Directors
RIVIERA BEACH, Fla., July 23, 2012 /PRNewswire-iReach/ -- Sancilio and Company, Inc. (SCI) is pleased to announce the recent addition of Dr. Alan Dunton, Mr. Patrick Gray, Mr. Rod Jackson, Dr. Dennis Langer and Mr. Kelly Perkins to its Board of Directors. The new directors join the Company's Chairman, Dr. Frederick Sancilio, who is also Founder, President and CEO.
"Our new directors are very well-known in the life sciences and financial industries. Their outstanding credentials, recognized leadership, and depth of executive experience are evidence of SCI's commitment to attract the highest quality leadership available. Each of our new directors is exceptionally well suited to help lead the Company into its next phase, and together will help grow our Company to new levels," said Dr. Sancilio.
SCI is a vertically integrated pharmaceutical company based in Riviera Beach, Florida focused on cardiovascular, dental and women's health products. SCI's products include Ocean Blue® Professional Omega-3 2100™, chewable and liquid prescription sodium fluorides, and prescription prenatal vitamins.
New Director Profiles
Dr. Alan Dunton
Dr. Dunton has over 25 years of experience as an executive in the pharmaceutical/biotechnology industry. Dr. Dunton is the founder and principal of Danerius, LLC, a consulting firm that works with small to mid-size pharmaceutical companies to guide them through drug development programs, assist them in identifying and evaluating product opportunities, and secure funding or partnering opportunities.
Prior to founding Danerius, Dr. Dunton held numerous positions in major pharmaceutical companies. Most recently, he served as President and Chief Executive Officer of Panacos Pharmaceuticals, Inc., and previously served as President and CEO of Metaphore Pharmac